journal article·2020-04-28Open access

Subcellular Mass Spectrometry Imaging and Absolute Quantitative Analysis across Organelles

Aurélien Thomen, Neda Najafinobar, Florent Penen, Emma Kay, Pratik P. Upadhyay, Xianchan Li, Nhu T. N. Phan, Per Malmberg, Magnus Klarqvist, Shalini Andersson, Michael E. Kurczy, Andrew G. Ewing

ACS Nano· Volume 14· Issue 4

Abstract

Mass spectrometry imaging is a field that promises to become a mainstream bioanalysis technology by allowing the combination of single-cell imaging and subcellular quantitative analysis. The frontier of single-cell imaging has advanced to the point where it is now possible to compare the chemical contents of individual organelles in terms of raw or normalized ion signal. However, to realize the full potential of this technology, it is necessary to move beyond this concept of relative quantification. Here we present a nanoSIMS imaging method that directly measures the absolute concentration of an organelle-associated, isotopically labeled, pro-drug directly from a mass spectrometry image. This is validated with a recently developed nanoelectrochemistry method for single organelles. We establish a limit of detection based on the number of isotopic labels used and the volume of the organelle of interest, also offering this calculation as a web application. This approach allows subcellular quantification of drugs and metabolites, an overarching and previously unmet goal in cell science and pharmaceutical development.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Mass Spectrometry Techniques and Applications · Ion-surface interactions and analysis · Analytical chemistry methods development

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Molecular Biology, University of Gothenburg, Gothenburg, 412 96, Sweden

Medicinal Chemistry, Research and Early Development, Respiratory, Inflammation, and Autoimmune, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 430 51, Sweden

Department of Chemistry and Chemical Engineering, Chalmers University of Technology, Gothenburg, 412 96, Sweden

Bioscience, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 430 51, Sweden

Pharmaceutical Technolgy and Development, AstraZeneca R&D, Gothenburg, 430 52, Sweden

Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China

Early Product Development, Pharmaceutical Science, R&D, AstraZeneca, Gothenburg, 431 50, Sweden

New Modalities, Discovery Sciences, R&D, AstraZeneca, Gothenburg, 430 51, Sweden

DMPK, Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, 430 51, Sweden

Funding

AstraZeneca · Vetenskapsrådet · Knut och Alice Wallenbergs Stiftelse · H2020 European Research Council

References (42)

Show source-provided references
1. 10.1016/S0273-2300(05)80055-810.1016/S0273-2300(05)80055-8 ↗
2. 10.1021/ac504734s10.1021/ac504734s ↗
3. 10.1038/clpt.2012.24010.1038/clpt.2012.240 ↗
4. 10.1016/j.ymeth.2014.05.00910.1016/j.ymeth.2014.05.009 ↗
5. 10.1073/pnas.170184811410.1073/pnas.1701848114 ↗
6. 10.1124/dmd.110.03599810.1124/dmd.110.035998 ↗
7. 10.1124/dmd.108.02637710.1124/dmd.108.026377 ↗
8. 10.1038/s41570-017-004810.1038/s41570-017-0048 ↗
9. 10.1016/j.semcdb.2013.05.00110.1016/j.semcdb.2013.05.001 ↗
10. 10.1111/j.1751-908X.2013.00239.x10.1111/j.1751-908X.2013.00239.x ↗
11. 10.1021/acsnano.6b0723310.1021/acsnano.6b07233 ↗
12. 10.1039/C6CC08549K10.1039/C6CC08549K ↗
13. 10.1038/nmeth.450410.1038/nmeth.4504 ↗
14. 10.1039/c3sc53426j10.1039/c3sc53426j ↗
15. 10.1039/C5CC06983A10.1039/C5CC06983A ↗
16. 10.1039/c3cc42098a10.1039/c3cc42098a ↗
17. 10.1039/C7MT00153C10.1039/C7MT00153C ↗
18. 10.1021/ac061825f10.1021/ac061825f ↗
19. 10.1016/j.jasms.2004.07.01010.1016/j.jasms.2004.07.010 ↗
20. 10.1136/jim-2016-00023910.1136/jim-2016-000239 ↗
21. 10.1073/pnas.162143211410.1073/pnas.1621432114 ↗
22. 10.1016/j.cmet.2018.03.01710.1016/j.cmet.2018.03.017 ↗
23. 10.1038/nature1073410.1038/nature10734 ↗
24. 10.1038/nrd219910.1038/nrd2199 ↗
25. Davission M. · 2008
26. 10.1063/1.34768710.1063/1.347687 ↗
27. 10.1016/j.chemgeo.2005.06.00110.1016/j.chemgeo.2005.06.001 ↗
28. 10.1002/anie.20150483910.1002/anie.201504839 ↗
29. 10.1017/S003358351600008110.1017/S0033583516000081 ↗
30. Howard J. · 2001 · 1 · 30
31. 10.1016/0016-7037(57)90024-810.1016/0016-7037(57)90024-8 ↗
32. 10.1002/ange.20150674310.1002/ange.201506743 ↗
33. 10.1002/anie.20150483910.1002/anie.201504839 ↗
34. 10.1523/JNEUROSCI.20-14-05276.200010.1523/JNEUROSCI.20-14-05276.2000 ↗
35. 10.1180/00264610054913910.1180/002646100549139 ↗
36. 10.1039/C4JA00319E10.1039/C4JA00319E ↗
37. 10.1021/acs.analchem.7b0278610.1021/acs.analchem.7b02786 ↗
38. 10.1039/C8FD00020D10.1039/C8FD00020D ↗
39. 10.1021/ac980129f10.1021/ac980129f ↗
40. Karnovsky M. · J. Cell Biol. · 1965 · 27 · 137
41. 10.1083/jcb.17.1.20810.1083/jcb.17.1.208 ↗
42. 10.1038/nmeth78210.1038/nmeth782 ↗